
UHS
Universal Health Services Inc
$
174.530
- Overview
- Forecast
- Valuation

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
185.2095
Open
183.360
VWAP
177.76
Vol
1.58M
Mkt Cap
11.38B
Low
173.620
Amount
280.38M
EV/EBITDA(TTM)
7.36
Total Shares
66.93M
EV
16.69B
EV/OCF(TTM)
8.07
P/S(TTM)
0.81
Universal Health Services, Inc. is a holding company. It operates through its subsidiaries, including its management company. It is engaged in owning and operating acute care hospitals and outpatient facilities, and behavioral healthcare facilities. ...Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
4.16B
+8.13%
4.400
+18.91%
4.23B
+8.28%
5.014
+16.34%
4.30B
+8.51%
4.457
+20.13%
Estimates Revision
The market is revisingUpwardthe revenue expectations for Universal Health Services, Inc. (UHS) for FY2025, with the revenue forecasts being adjusted by 2.57%over the past three months. During the same period, the stock price has changed by-3.61%.
Revenue Estimates for FY2025
Revise Upward

+2.57%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+5.75%
In Past 3 Month
Stock Price
Go Down

-3.61%
In Past 3 Month
11 Analyst Rating

30.64% Upside
Wall Street analysts forecast UHS stock price to riseover the next 12 months. According to Wall Street analysts, the average 1-year price target for UHS is 228.00USD with a low forecast of200.00USD and a high forecast of267.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
6 Hold
0 Sell
Moderate Buy

30.64% Upside
Current: 174.530

Low
200.00
Averages
228.00
High
267.00
Morgan Stanley
Craig Hettenbach
Hold
Initiates
$200
2025-03-26
Reason
Morgan Stanley initiated coverage of Universal Health with an Equal Weight rating and $200 price target. The firm likes the company's leadership in inpatient behavioral health but says uncertainty around potential government spending cuts is a near-term overhang on the shares. However, Universal Health is executing well and the business should return to a "more normal cadence following a period of greater variability and distortions around the pandemic," the analyst tells investors in a research note.
Wells Fargo
Stephen Baxter
Buy
Maintains
$230 → $225
2025-03-10
Reason
Wells Fargo lowered the firm's price target on Universal Health to $225 from $230 to reflect greater uncertainty, while keeping an Overweight rating on the shares. Underlying results in Q4 were fairly strong despite some softness in demand, the firm says. Core guidance was ahead of Wells' estimates, but does not include new Medicaid supplemental pricing in TN and D.C.
Stephens & Co.
Scott Fidel
Hold
Maintains
$210 → $223
2025-02-28
Reason
Stephens & Co.
Raj Kumar
Hold
Reiterates
$210
2025-02-27
Reason
Barclays
Andrew Mok
Buy
Maintains
$271 → $249
2025-02-27
Reason
Barclays analyst Andrew Mok lowered the firm's price target on Universal Health to $249 from $271 and keeps an Overweight rating on the shares post the Q4 report. The company reported a solid beat while absorbing higher malpractice costs and guided to 5%-11% EBITDA growth without any contribution from new state supplemental programs, the analyst tells investors in a research note.
JP Morgan
Benjamin Rossi
Hold
Initiates
$226
2024-12-17
Reason
JPMorgan assumed coverage of Universal Health with a Neutral rating and $226 price target. The firm believes favorable trends across sales and expenses for managed care companies should allow for margin expansion in 2025, but considers the setup into 2026 to be more bearish, saying potential volume rollover and regulatory uncertainty following the November elections present an "imperfect storm" of payer mix headwinds and a negative overhang on go-forward sentiment for the hospitals.
TD Cowen
Ryan Langston
Strong Buy
Maintains
$275 → $251
2024-11-26
Reason
TD Cowen analyst Ryan Langston lowered the firm's price target on Universal Health to $251 from $275 and keeps a Buy rating on the shares. The firm said UHS is a best idea for 2025. The incoming administration and market sentiment add risk to the pick and acknowledge the potential for revisions to entitlement programs and other headwinds.
Wells Fargo
Stephen Baxter
Buy
Maintains
$285 → $230
2024-11-25
Reason
Wells Fargo lowered the firm's price target on Universal Health to $230 from $285 and keeps an Overweight rating on the shares. The firm cut out-year estimates for the hospitals to reflect its assumption that enhanced exchange subsidies will expire. Current policy and fiscal uncertainty warrant lower multiples in the group, the analyst tells investors in a research note. Wells sees the extension of enhanced exchange subsidies as unlikely following the Republican sweep. Assuming the expiration of enhanced subsidies was a 50% probability before the election and a 100% probability now, the group multiples are little changed since the election, contends Wells. It expects "uncertainty to remain high for some time."
Wells Fargo
Stephen Baxter
Buy
Maintains
$275 → $285
2024-11-06
Reason
Wells Fargo analyst Stephen Baxter raised the firm's price target on Universal Health to $285 from $275 and keeps an Overweight rating on the shares. Following Q3 earnings, the firm is updating models and detailed earnings bridges for each Hospital. Wells note that core revisions are for the most part relatively small, but there are impacts from Hurricane impacts and revised Medicaid supplemental payment assumptions that drive changes.
RBC Capital
Frank Morgan
Hold
Maintains
$222 → $211
2024-10-28
Reason
RBC Capital lowered the firm's price target on Universal Health to $211 from $222 and keeps a Sector Perform rating on the shares. Results fell within management's internal expectations amid tougher year over year comps, and RBC came away from the results encouraged by management's sizing of incremental Medicaid supplemental programs expected to kick in next year, which should support solid growth, the analyst tells investors in a research note.
Valuation Metrics
The current forward P/E ratio for Universal Health Services Inc(UHS.N) is 9.20, compared to its 5-year average forward P/E of 12.09. For a more detailed relative valuation and DCF analysis to assess Universal Health Services Inc 's fair value, click here.
Forward PE

Undervalued
5Y Average PE
12.09
Current PE
9.20
Overvalued PE
13.78
Undervalued PE
10.40
Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
8.10
Current EV/EBITDA
7.04
Overvalued EV/EBITDA
8.88
Undervalued EV/EBITDA
7.32
Forward PS

Fair
5Y Average PS
0.77
Current PS
0.72
Overvalued PS
0.91
Undervalued PS
0.64
Financials
Annual
Quarterly
FY2024Q4
YoY :
+11.08%
4.11B
Total Revenue
FY2024Q4
YoY :
+42.66%
472.49M
Operating Profit
FY2024Q4
YoY :
+53.47%
337.05M
Net Income after Tax
FY2024Q4
YoY :
+56.96%
4.96
EPS - Diluted
FY2024Q4
YoY :
+67.65%
412.49M
Free Cash Flow
FY2024Q4
YoY :
0.00%
100.00
Gross Profit Margin - %
FY2024Q4
YoY :
+38.11%
8.19
Net Margin - %
FY2024Q4
YoY :
+43.91%
11.47
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
308.5K
USD
1
6-9
Months
1.1M
USD
2
0-12
Months
4.7M
USD
5
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
2.3M
Volume
4
Bought
0-3
0
0.0
Volume
Months
3-6
2
280.8K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
4
165.7K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
UHS News & Events
Events Timeline
2025-03-25 (ET)
2025-03-25
09:55:01
Early notable gainers among liquid option names on March 25th

2025-02-26 (ET)
2025-02-26
16:17:51
Universal Health sees FY25 EPS $18.45-$19.95, consensus $18.16

2025-02-26
16:16:33
Universal Health reports Q4 adjusted EPS $4.92, consensus $4.18

2025-02-26
14:06:38
Notable companies reporting after market close

2025-02-06 (ET)
2025-02-06
12:32:11
White House readying order to fire thousands of federal health workers, WSJ says


2024-10-24 (ET)
2024-10-24
16:17:04
Universal Health reports Q3 adjusted EPS $3.71, consensus $3.70

2024-10-24
13:45:05
Notable companies reporting after market close

2024-10-24
12:04:11
Community Health says increased denials 'relatively broad based'

2024-10-16 (ET)
2024-10-16
09:55:01
Early notable gainers among liquid option names on October 16th

2024-10-14 (ET)
2024-10-14
10:07:22
Universal Health says post-trial motions may reduce Pavilion punitive damages


2024-09-30 (ET)
2024-09-30
09:58:37
Universal Health falls after jury finds Cumberland subsidiary liable


News
4.0
04-01NASDAQ.COMIs Universal Health Stock Underperforming the Dow?
4.5
03-26NASDAQ.COMS&P 500 Movers: SYK, CTAS
6.0
03-26BenzingaMorgan Stanley Initiates Coverage On Universal Health Services with Equal-Weight Rating, Announces Price Target of $200
8.0
03-21NASDAQ.COMCommit To Buy Universal Health Services At $155, Earn 9.3% Annualized Using Options
1.0
03-11PRnewswireUNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT KEYBANC CAPITAL MARKETS VIRTUAL HEALTHCARE FORUM
4.0
03-10BenzingaWells Fargo Maintains Overweight on Universal Health Services, Lowers Price Target to $225
4.0
03-10Business InsiderUniversal Health price target lowered to $225 from $230 at Wells Fargo
1.0
03-03NASDAQ.COMUniversal Health Services To Present At TD Cowen Health Care Conference; Webcast At 9:10 AM ET
4.5
02-28NASDAQ.COMFriday Sector Laggards: Technology & Communications, Healthcare
2.0
02-28SeekingAlphaHospital stocks fall amid Medicaid funding concerns
4.0
02-28NASDAQ.COMValidea John Neff Strategy Daily Upgrade Report - 2/28/2025
4.5
02-28NASDAQ.COMChip Stock Weakness and Tariff Angst Sink Stocks
4.5
02-27NASDAQ.COMNasdaq Slumps on Nvidia Weakness as Tariff Anxieties Loom Large
4.5
02-27NASDAQ.COMStocks Trade Mixed as Chip Stocks Slide
4.5
02-27NASDAQ.COMStocks Give Up Early Gains on Tariff Concerns
8.0
02-27NASDAQ.COMEx-Dividend Reminder: Clearway Energy, Universal Health Services and McKesson
3.0
02-27NASDAQ.COMUniversal Health Services Q4 24 Earnings Conference Call AT 10:00 AM ET
4.5
02-27NASDAQ.COMStocks Post Modest Gains Ahead of Nvidia's Earnings
9.5
02-26SeekingAlphaUniversal Health Services Non-GAAP EPS of $4.92 beats by $0.74, revenue of $4.11B beats by $100M
4.5
02-26NASDAQ.COMStocks Gain on Positive Corporate News
People Also Watch

ACMR
ACM Research Inc
20.300
USD
-9.17%

IGIC
International General Insurance Holdings Ltd
22.610
USD
-13.11%

STAA
STAAR Surgical Co
15.920
USD
-8.51%

FBMS
First Bancshares Inc (Mississippi)
33.810
USD
+0.48%

EMBC
Embecta Corp
12.000
USD
-2.99%

PSFE
Paysafe Ltd
14.160
USD
-5.35%

PMT
PennyMac Mortgage Investment Trust
13.670
USD
-5.27%

PDM
Piedmont Office Realty Trust Inc
6.680
USD
-3.47%

OCFC
OceanFirst Financial Corp
15.070
USD
-3.09%

IRS
IRSA Inversiones y Representaciones SA
12.550
USD
-2.86%
FAQ

What is Universal Health Services Inc (UHS) stock price today?
The current price of UHS is 174.53 USD — it hasdecreased-7.52 % in the last trading day.

What is Universal Health Services Inc (UHS)'s business?

What is the price predicton of UHS Stock?

What is Universal Health Services Inc (UHS)'s revenue for the last quarter?

What is Universal Health Services Inc (UHS)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Universal Health Services Inc (UHS)'s fundamentals?

How many employees does Universal Health Services Inc (UHS). have?
